Andrej Vranovský
Impact in
-
- Lymphoma Diagnosis and Treatment
- Hematology top 2%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
Papers in
-
- Lymphoma Diagnosis and Treatment 17
-
- Multiple Myeloma Research and Treatments 2
- Acute Myeloid Leukemia Research 1
- Hematopoietic Stem Cell Transplantation 1
- Chronic Myeloid Leukemia Treatments 1
- Co-authors
- Anton Hagenbeek (4 shared papers)Martine M. Van Glabbeke (3 shared papers)Harald Holte (3 shared papers)Marinus H. J. van Oers (3 shared papers)Richard John Klasa (3 shared papers)Eva K. Kimby (3 shared papers)Max M. Wolf (3 shared papers)Robert E Marcus (3 shared papers)
- Journals
- Blood (5 papers)The Lancet (2 papers)Journal of Clinical Oncology (2 papers)HemaSphere (1 paper)International Journal of Radiation Oncology*Biology*Physics (1 paper)
- Partner nations
- NetherlandsBelgiumSlovakia
In The Last Decade
Andrej Vranovský
20 papers receiving 1.4k citations
Andrej Vranovský's Hit Papers
Peers
Comparison fields: 5 of 43
- Pathology and Forensic Medicine 733
- Hematology 505
- Genetics 67
- Oncology 79
- Radiology, Nuclear Medicine and Imaging 58
Countries citing papers authored by Andrej Vranovský
This map shows the geographic impact of Andrej Vranovský's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrej Vranovský with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrej Vranovský more than expected).
Fields of papers citing papers by Andrej Vranovský
This network shows the impact of papers produced by Andrej Vranovský. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrej Vranovský. The network helps show where Andrej Vranovský may publish in the future.
Co-authors
The 25 scholars most cited alongside Andrej Vranovský, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a randomised, multicentre, open-label, phase 3 study Hit paper breakdown → | 2019 | 521 |
| 2 | Rituximab maintenance improves clinical outcome of relapsed/resistant follicular non-Hodgkin lymphoma in patients both with and without rituximab during induction: results of a prospective randomized phase 3 intergroup trial Hit paper breakdown → | 2006 | 486 |
| 3 | 2010 | 252 | |
| 4 | 2010 | 46 | |
| 5 | 2017 | 27 | |
| 6 | 2005 | 26 | |
| 7 | 2014 | 26 | |
| 8 | 2017 | 20 | |
| 9 | 2019 | 9 | |
| 10 | 2002 | 8 | |
| 11 | 2007 | 7 | |
| 12 | 2010 | 7 | |
| 13 | 2021 | 5 | |
| 14 | 2007 | 3 | |
| 15 | 2009 | 3 | |
| 16 | Autologous stem cell transplantation with selected CD34+ cells and unmanipulated peripheral blood stem cells in patients with relapsed and refractory Hodgkin's lymphoma: a single centre experience. | 2008 | 2 |
| 17 | 2022 | 2 | |
| 18 | 2002 | 1 | |
| 19 | Autologous stem cell transplantation in first-line treatment of high-risk aggressive non-Hodgkin's lymphoma. | 2008 | 1 |
| 20 | 2024 | 1 |
About Andrej Vranovský
Andrej Vranovský is a scholar working on Pathology and Forensic Medicine, Hematology, Genetics, Oncology and Epidemiology, having authored 23 papers that have together received 1.5k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (17 papers), Chronic Lymphocytic Leukemia Research (2 papers), CAR-T cell therapy research (2 papers), Multiple Myeloma Research and Treatments (2 papers), Acute Myeloid Leukemia Research (1 paper), Multiple and Secondary Primary Cancers (1 paper), Hematopoietic Stem Cell Transplantation (1 paper) and Chronic Myeloid Leukemia Treatments (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (733 citations), Hematology (505 citations), Genetics (67 citations), Oncology (79 citations) and Radiology, Nuclear Medicine and Imaging (58 citations). Andrej Vranovský has collaborated with scholars based in Netherlands, Belgium and Slovakia. Frequent co-authors include Anton Hagenbeek, Martine M. Van Glabbeke, Harald Holte, Marinus H. J. van Oers, Richard John Klasa, Eva K. Kimby, Max M. Wolf, Robert E Marcus, Mars B. vanʼt Veer and Andrew Jack. Their work appears in journals such as Blood, The Lancet, Journal of Clinical Oncology, HemaSphere and International Journal of Radiation Oncology*Biology*Physics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.